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Abstract
Many cases of coeliac disease, a gastrointestinal autoimmune disorder caused by sensitivity to
gluten, can remain in a subclinical stage or undiagnosed. In a significant proportion of cases (10–
15%) gluten intolerance can be associated with central or peripheral nervous system and
psychiatric disorders.
A 38-year-old man was admitted as to our department an inpatient for worsening anxiety
symptoms and behavioural alterations. After the addition of second generation antipsychotic to the
therapeutic regimen, the patient presented neuromotor impairment with high fever, sopor,
leukocytosis, raised rhabdomyolysis-related indicators. Neuroleptic malignant syndrome was
strongly suspected. After worsening of his neuropsychiatric conditions, with the onset of a frontal
cognitive deficit, bradykinesia and difficulty walking, dysphagia, anorexia and hypoferraemic
anaemia, SPET revealed a reduction of cerebral perfusion and ENeG results were compatible with
a mainly motor polyneuropathy. Extensive laboratory investigations gave positive results for anti-
gliadin antibodies, and an appropriate diet led to a progressive remission of the encephalopathy.
Introduction
Coeliac disease is an inflammatory disease of the upper
small intestine resulting from gluten ingestion [1]. The
diagnosis is based on: a clinical picture suggesting malab-
sorption of nutrients, serology for anti-gliadin, anti-
endomysial and anti-transglutaminase antibodies, some-
times a biopsy of the intestinal mucosa, and resolution of
the lesions following the institution of a gluten-free diet
[1]. Many cases of coeliac disease long remain in a sub-
clinical stage [2], or undiagnosed because of poor aware-
ness of the condition among primary care physicians [1].
In a significant proportion of cases (10–15%) gluten
intolerance can be associated with central or peripheral
nervous system disorders, such as cerebellar ataxia, myo-
clonus, epilepsy, ophthalmoplegia, dementia, multifocal
leukoencephalopathy, peripheral neuropathies and
myopathies [3] and with psychiatric disorders such as
anxiety, depression, psychotic symptoms and personality
disorders [4]. These manifestations are sometimes the pre-
senting symptoms of the disease [4-6]. The physiopatho-
logical mechanisms underlying these associations are still
not known, even though genetic causes [6] and autoim-
mune factors [7,8] have been hypothesised.
The literature describes cases of cerebral perfusion abnor-
malities in untreated coeliac patients [9,10]. There is also
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a report of a case of regression of frontal hypoperfusion
following the institution of a gluten-free diet [9].
Case report
In May 2001, a 38-year-old man with anxious-depressive
symptoms was referred to us for psychiatric assessment.
These symptoms, occurring sporadically for around two
years, had worsened following a protracted absence from
work (due to a disabling right wrist fracture). The patient
had a history of surgical operations to correct kyphoscol-
iosis.
He was diagnosed with reactive depressive disorder in the
context of personality disorder NOS (not otherwise speci-
fied) and put on paroxetine 10 mg with benzodiazepines.
Following the appearance of bizarre behaviours and het-
eroaggressiveness towards family members, anti-psy-
chotic therapy (haloperidol decanoate 50 mg every four
weeks) was added. In May 2002, worsening anxiety symp-
toms and behavioural alterations that could not be man-
aged at home culminated in the patient's hospitalisation
in our department for re-assessment and review of ther-
apy. Two days after the addition of risperidone 2 mg to the
existing therapeutic regimen (citalopram 20 mg and BDZ)
the patient presented muscle rigidity, cramp-like muscle
pain and increased osteo-tendinous reflexes leading to
bradykinesia and difficulty walking. Withdrawal of the
anti-psychotic drug did not improve the picture signifi-
cantly. Laboratory investigations revealed raised CK (536
U/l) and a brain CT-scan showed an area of hypodensity
of possible ischaemic origin in the posterior fossa, as well
as moderate deepening of the cortical sulci in the frontal-
temporal region bilaterally. EEG showed mild, non-spe-
cific, non-focal abnormalities.
The severe anxiety symptoms and behavioural alterations
persisted and a week later anti-psychotic treatment was re-
introduced. The clinical picture, already characterised by
neuromotor impairment, worsened abruptly and unex-
pectedly, with the onset of high fever (39°C), sopor, acute
respiratory insufficiency with peripheral cyanosis, leuko-
cytosis (WBC count 16680/mm3), and raised rhabdomy-
olysis-related indicators (CK 1216 U/l and LDH 718 U/l).
The patient was transferred to the infectious diseases
department. Since neuroleptic malignant syndrome was
strongly suspected, the anti-psychotic was withdrawn and
dantrolene 50 mg/day and cardiorespiratory support were
started, substantially resolving the acute symptomatology.
The patient developed an Enterococcus faecalis infection of
the urinary tract and deep-vein thrombosis (DVT), which
were treated with antibiotic therapy and subcutaneous
heparin.
Although the patient's general conditions improved, the
neurological picture of diffuse muscle rigidity, psychomo-
tor slowing and dysarthria persisted and despite further
investigations (MRI, evaluation of autoantibodies and cir-
culating immunocomplexes) continued to lack a plausi-
ble explanation.
In mid-June, a further worsening of his neuropsychiatric
conditions prompted his readmission to our department.
During this second stay, he displayed the progressive
onset of a frontal cognitive deficit together with affective
lability, behavioural and affective regression, and verbal
and motor stereotypes. Furthermore, the appearance of
dysphagia and anorexia led to significant weight loss (20
kg in two months) which necessitated parenteral nutri-
tion.
The patient was then sent to the Neuropathology Unit at
the "C. Besta" Neurological Institute in Milan, where sin-
gle photon emission computed tomography (SPECT)
revealed a reduction of perfusion and thus of neuronal
activity and density in the right superior and middle fron-
tal gyri, the left superior frontal gyrus, and the left medial
temporal and occipital gyri; electroneurography (ENeG)
results were compatible with a mainly motor polyneurop-
athy. Subsequently, mild hypoferraemic anaemia was
found. Gluten sensitivity tests (part of further and more
extensive laboratory investigations) gave positive results
for anti-gliadin (IgG 32 UI/ml), anti-endomysial and anti-
transglutaminase antibodies). A appropriate diet was
instituted and led to a progressive remission of the
encephalopathy and an improvement in the psychiatric
symptoms and the lesions detected on SPECT and ENeG,
which, at follow up, were no longer present. After a period
of rehabilitation, this patient is still followed by our psy-
chiatric service for mild anxiety symptoms. He takes olan-
zapine 2.5 mg and derives benefit from the treatment.
Conclusion
The diagnostic process in this patient proved particularly
complicated. This is, in fact, a case of clinical onset of coe-
liac disease in adulthood, without signs of malabsorption
and with exclusively psychiatric involvement (non-spe-
cific anxious-depressive symptoms associated with affec-
tive and behavioural personality disorders). In our view,
this clinical picture could be attributed to the SPET-docu-
mented frontal hypoperfusion. This would indeed explain
the lack of benefit of the initial psychopharmacological
treatment and the progressive worsening of the symptoms
that, together with the onset of behavioural disinhibition,
necessitated the patient's hospitalisation. During hospi-
talisation, the administration of anti-psychotic drugs trig-
gered the onset of neuroleptic malignant syndrome,
which, initially atypical (without fever and leukocytosis)
and then full blown, slowed down the diagnostic process
and delayed the recognition of the true nature (organic) of
the aetiology. We cannot rule out the possibility that thisPublish with BioMed Central    and   every 
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coeliac patient presented a particular susceptibility to this
rare complication associated with the use of second-gen-
eration antipsychotic drugs [11], given the cerebral
involvement documented on brain CT-scan and subse-
quently on SPECT. The picture was complicated further by
the onset of DVT and a urinary tract infection, probably
due to the patient's prolonged confinement to bed.
After the resolution of the acute picture, there remained a
progressively worsening psycho-organic syndrome, sec-
ondary to the above-mentioned cerebral involvement,
and neuromotor deficits due to the polyneuropathy
detected on ENeG. The case we describe recalls literature
reports of an adult-onset progressive frontal, subcortical-
type cognitive deficit, characterised by confusion, person-
ality disturbances and associated neurological (ataxia-
and peripheral neuropathy-type) pictures, coinciding
with the exacerbation of a malabsorption syndrome [12].
The appearance of the first signs pointing to malabsorp-
tion, i.e., the weight loss and hypoferraemic anaemia,
finally prompted us to investigate a possible autoimmune
aetiology, and to test for anti-gliadin antibodies, for
which the patient was positive.
The diagnostic hypothesis of gluten encephalopathy was
confirmed by the remission of the symptoms and of the
lesions observed on SPECT following the institution of an
appropriate diet.
In addition to the objective diagnostic difficulties pre-
sented by this case, we wish to add a further, ideological
consideration, relating to an unwitting tendency of col-
leagues from other specialist disciplines to stigmatise
patients classified as "psychiatric". Indeed, both the possi-
ble organic aetiology of the clinical picture and the con-
comitant medical disorders presented by "psychiatric"
patients are often underestimated, slowing down the diag-
nostic process and the taking of the necessary therapeutic
measures.
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